These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2448865)

  • 1. Natural killer cell activity in hepatocellular carcinoma. In vitro and in vivo responses to interferon.
    Dunk AA; Novick D; Thomas HC
    Scand J Gastroenterol; 1987 Dec; 22(10):1245-50. PubMed ID: 2448865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
    Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
    J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
    Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer (NK) cell activity and its in vitro response to interferon-alpha(Le) in chronic liver diseases and hepatocellular carcinoma.
    Hirai N; Kato Y; Kobayashi K; Hattori N
    Liver; 1986 Aug; 6(4):212-20. PubMed ID: 3022099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
    Kamiya T; Chang YH; Campana D
    Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.
    Nakajima T; Mizushima N; Kanai K
    Jpn J Clin Oncol; 1987 Dec; 17(4):327-32. PubMed ID: 2826847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function.
    Jiang W; Zhang C; Tian Z; Zhang J
    Gene Ther; 2013 Nov; 20(11):1062-9. PubMed ID: 23759701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural killer cell activity of the peripheral blood in patients with hepatocellular carcinoma].
    Lin ZY; Weng HZ; Tang ZY; Wang QD
    Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):417-20. PubMed ID: 2438105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion.
    Chuang WL; Liu HW; Chang WY
    Cancer; 1990 Feb; 65(4):926-30. PubMed ID: 2153437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
    Su Z; Ye X; Shang L
    Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.
    Yu M; Luo H; Fan M; Wu X; Shi B; Di S; Liu Y; Pan Z; Jiang H; Li Z
    Mol Ther; 2018 Feb; 26(2):366-378. PubMed ID: 29339014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
    Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
    Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole.
    Son K; Kew M; Rabson AR
    Cancer; 1982 Dec; 50(12):2820-5. PubMed ID: 6182983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective interferon-augmented natural killer cell activity in patients with metastatic malignant melanoma.
    Müller C; Pehamberger H; Binder M; Zielinski CC
    J Cancer Res Clin Oncol; 1989; 115(4):393-6. PubMed ID: 2474550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
    Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of peripheral NK cells in hepatocellular carcinoma patients].
    Zhou L; Cai L; Zhang Z; Yang YP; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):136-9. PubMed ID: 20196954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 reinvigorates exhausted natural killer cells in patients with HBV-associated hepatocellular carcinoma in STAT1-depedent pathway.
    Jin Y; Sun Z; Geng J; Yang L; Song Z; Song H; Wang J; Tang J
    Int Immunopharmacol; 2019 May; 70():1-8. PubMed ID: 30780004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.
    Wang FS; Liu MX; Zhang B; Shi M; Lei ZY; Sun WB; Du QY; Chen JM
    World J Gastroenterol; 2002 Jun; 8(3):464-8. PubMed ID: 12046071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taste receptor T1R1/T1R3 promotes the tumoricidal activity of hepatic CD49a
    Liu S; Xu M; Zhu C; Zhao Q; Zhou F
    Eur J Immunol; 2018 Dec; 48(12):2031-2041. PubMed ID: 30259960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.